CSIR-Institute of Genomics and Integrative Biology
Delhi, Delhi, India
Purpose
To advance the development of an affordable, bedside gene editing platform for sickle cell disease that could provide curative treatment for patients in India and other low- and middle-income countries where the disease burden is highest.
Division
Africa & India Offices
Date
August 2026
Region Served
ASIA
Committed amount
$515,761
Grant topic
Global Health and Development Public Awareness and Analysis
Duration (months)
24
Grantee location
Delhi, Delhi, India
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.